IP Library Granted Patent US 11,000,288
Granted Patent B2
US 11,000,288 · App. 16/273,008 · Granted May 11, 2021

Inflatable implant

Inventors: W. Patrick Stephens (Santa Rosa, CA); Gerald Ray Martin (Windsor, CA)
Assignee: TriVascular, Inc.
A61B17/12113A61B17/12022A61B17/12136A61B17/12159A61B17/12195
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,000,288
App. No.
16/273,008
Granted
May 11, 2021
Kind
B2
Abstract

Described is an inflatable implant suitable for placement in the human body and left there for an indeterminate and potentially lengthy period of time. The implant includes at least one bladder wall. The bladder wall will define at least one fillable volume and may form more than one independent fillable volumes. The wall and filler material may be selected to deliver treatment materials to the locale of the implant site or to remove amounts of harmful materials from such a region. The implant may, with an appropriate filler material or bladder wall material, be used in cooperation with an appropriate radio frequency (RF) source to cause the increase of a localized internal temperature and a resulting tissue change such as coagulation, ablation, or the like. Methods of using the implant are also described.

Claims (15)

1. An inflatable, expandable implant suitable for implantation in a human body, comprising: a bladder comprising

a substantially non-elastic bladder wall defining a volume and having at least one bladder wall opening for introduction of filler material; and

an elastic bladder wall defining a volume and having at least one bladder wall opening for introduction of the filler material.

2. The implant of claim 1 , further comprising at least one closure for each of the bladder wall openings for maintaining the filler material within the volume after introduction of the filler material into the volume.

3. The implant of claim 1 , where the substantially non-elastic and elastic bladder walls comprise fabrics selected from the group consisting of woven fabric and non-woven fabric.

4. The implant of claim 1 , where the substantially non-elastic bladder wall comprises at least one member selected from the group consisting of polyethyleneterephthalate, polyvinylchloride, polyurethanes, polyolefins, polyamides, and fluoropolymers.

5. The implant of claim 1 , where the substantially non-elastic bladder wall comprises at least one fluoropolymer selected from the group consisting of polytetrafluoroethylene, poly(ethylene-chlorofluoroethylene), poly(fluorinated ethylene propylene), polyperfluoroalkoxy, polychlorotrifluoroethylene, polyvinylfluoride, polyvinylidenefluoride, and expanded polytetrafluoroethylene.

6. The implant of claim 1 , where the substantially non-elastic bladder wall comprises expanded polytetrafluoroethylene.

7. The implant of claim 1 further comprising the filler material.

8. The implant of claim 7 wherein the filler material is a filling liquid.

9. The implant of claim 8 wherein the filling liquid is selected from the group consisting of water, saline, and biocompatible liquids.

10. The implant of claim 7 wherein the filler material contains bioactive or chemi-active material.

11. The implant of claim 7 wherein the filler material comprises a reactive mixture adapted to react within the bladder volume.

12. The implant of claim 7 wherein the filler material comprises a member selected from the group consisting of elastic solids, viscoelastic solids, viscoelastic liquids, viscoelastic liquids comprising gel microparticles, viscous liquids, and their precursors.

13. The implant of claim 7 wherein the filler material comprises a copolymer of a first member selected from the group consisting of poly(ethylene glycol), poly(ethylene oxide), poly(vinyl alcohol), poly(ethylene-co-vinyl alcohol), poly(acrylic acid), poly(ethylene-co-acrylic acid), poly(ethyloxazoline), poly(vinyl pyrrolidone), poly(ethylene-co-vinyl pyrrolidone), poly(maleic acid), poly(ethylene-co-maleic acid), poly(acrylamide), and poly(ethylene oxide)-co-poly(propylene oxide) block copolymers and a second member having a strong nucleophile selected from the group consisting of a thiol or a group containing a thiol.

Assignments (6)
SECURITY INTEREST Recorded Apr 1, 2021
From: TRIVASCULAR, INC.
To: SILICON VALLEY BANK
Reel/Frame 055794/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2020
From: STEPHENS, W. PATRICK; MARTIN, GERALD RAY
To: TRIVASCULAR, INC.
Reel/Frame 054342/0183 →
SECURITY INTEREST Recorded Oct 2, 2020
From: ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.); NELLIX, INC.; TRIVASCULAR TECHNOLOGIES, INC.; TRIVASCULAR, INC.; TRIVASCULAR CANADA, LLC
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P.
Reel/Frame 053971/0052 →
CHANGE OF NAME Recorded Oct 2, 2020
From: ENDOLOGIX, INC.
To: ENDOLOGIX LLC
Reel/Frame 053971/0135 →
SECURITY INTEREST Recorded Apr 2, 2019
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT
Reel/Frame 048772/0612 →
SECURITY INTEREST Recorded Apr 2, 2019
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 048772/0772 →
Continuity (3)
Continuation 12628623 · Dec 1, 2009
Division 10461853 · Jun 13, 2003
Related Publication 20190167272A1 · Jun 6, 2019